| 000 | 05110namaa22004331i 4500 | ||
|---|---|---|---|
| 003 | OSt | ||
| 005 | 20250921103111.0 | ||
| 008 | 250818s2024 ua a|||frm||| 000 0 eng d | ||
| 040 |
_aEG-GICUC _beng _cEG-GICUC _dEG-GICUC _erda |
||
| 041 | 0 |
_aeng _beng _bara |
|
| 049 | _aDeposit | ||
| 082 | 0 | 4 | _a616.99466 |
| 092 |
_a616.99466 _221 |
||
| 097 | _aM.Sc | ||
| 099 | _aCai01.19.04.M.Sc.2024.Mo.R | ||
| 100 | 0 |
_aMostafa Abdelgwad Abdelkrem Abdelgwad, _epreparation. |
|
| 245 | 1 | 0 |
_aRole of pipelle biopsy in endometrial cancer : _bA comparative study with conventional dilatation and curettage biopsy / _cby Mostafa Abdelgwad Abdelkrem Abdelgwad ; Supervised Prof. Dr. Mohamed Elzohairy, Dr. Mohamed Ayaty, Dr. Mohamed Abdalla Zaakouk. |
| 246 | 1 | 5 |
_aدور عينة بابيل في سرطان بطانة الرحم : _bدراسه مقارنه مع عينة الكحت / |
| 264 | 0 | _c2024. | |
| 300 |
_a53 pages : _billustrations ; _c25 cm. + _eCD. |
||
| 336 |
_atext _2rda content |
||
| 337 |
_aUnmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 502 | _aThesis (M.Sc)-Cairo University, 2024. | ||
| 504 | _aBibliography: pages 50-53. | ||
| 520 | 3 | _aEndometrial cancer is the most common gynecologic cancer in developed countries. The diagnosis of endometrial cancer is based on the histologic results of endometrial sampling. Endometrial biopsy could be obtained using different modalities: hysteroscopy-directed endometrial biopsy, uterine curettage or office endometrial biopsy. The most popular office-based device for endometrial sampling procedure is the Pipelle device. Currently, Pipelle endometrial sampling is widely used to diagnose endometrial cancer in women with abnormal uterine bleeding and/or postmenopausal bleeding. The method became very useful due to easiness and simplicity of the procedure, availability of a device, as well as high sensitivity in detecting endometrial cancer. Many studies compared the validity and accuracy of Pipelle biopsy with dilation and curettage in the detection of various endometrial pathologies. Published results state that Pipelle biopsy and uterine curettage are almost equally reliable in the evaluation of endometrial pathologies. Moreover, Pipelle biopsy appears more beneficial as it does not require hospital admission and anesthesia. However, it is proven the Pipelle technique has a limited capacity to identify endometrial polyps, and some authors, based on their study, claim that dilation and curettage is a more reliable method in terms of correlation with the final histological results. In addition, there are many factors affecting the efficiency of the endometrial biopsy. Failure to get samples that are adequate for histological examination is one of the problems associated with Pipelle sampling. The above-mentioned contradictory conclusions by different researchers and lack of guidance to avoid inadequate sampling present the demand for further studies on the comparison of Pipelle biopsy and uterine curettage efficiency and accuracy. Objective: To evaluate accuracy of pipelle endometrial -biopsy in diagnosis of endometrial cancer in comparison with dilatation and curettage. | |
| 520 | 3 | _aأمراض بطانة الرحم هي مشاكل متكررة في ممارسة أمراض النساء، وخاصة في النساء قبل انقطاع الطمث وبعد انقطاع الطمث. يتم استخدام العديد من تقنيات أخذ عينات بطانة الرحم لتشخيص أمراض بطانة الرحم للمرضى الذين يعانون من نزيف الرحم. يعتبر أخذ عينة من بطانة الرحم من خلال Pipelle وسيلة سهلة وغير مكلفة مع الحد الأدنى من عدم الارتياح والألم للمريض وطريقة آمنة للحصول على تشخيص الأنسجة. وكذلك يمكن إجراؤها للمرضى في العيادات الخارجية وبدون تخدير. تعتبر هذه الطريقة في نفس فعالية كحت الرحم في تقييم المرضى الذين يعانون من نزيف الرحم مع دقة 98.1٪ و 0.9 و حساسية 88.89٪ ونوعية 100٪ مقارنة بكحت الرحم. ومع ذلك، هناك حاجة إلى دراسات واسعة النطاق تشمل عددًا أكبر من الحالات وفئات عمرية مختلفة لدعم هذه البيانات. | |
| 530 | _aIssues also as CD. | ||
| 546 | _aText in English and abstract in Arabic & English. | ||
| 650 | 0 | _aEndometrial cancer | |
| 653 | 1 |
_apostmenopausal bleeding _aendometrial cancer _aendometrial sampling _apipelle _adilation and curettage. |
|
| 700 | 0 |
_aMohamed Elzohairy _ethesis advisor. |
|
| 700 | 0 |
_a Mohamed Ayaty _ethesis advisor. |
|
| 700 | 0 |
_aMohamed Abdalla Zaakouk _ethesis advisor. |
|
| 900 |
_b01-01-2024 _cMohamed Elzohairy _cMohamed Ayaty _cMohamed Abdalla Zaakouk _UCairo University _FNational Cancer Institute _DDepartment of Oncosurgery |
||
| 905 |
_aShimaa _eEman Ghareb |
||
| 942 |
_2ddc _cTH _e21 _n0 |
||
| 999 | _c173614 | ||